Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C
- Bita Behnava
- Heidar Sharafi
- Maryam Keshvari
- Ali Pouryasin
- Leila Mehrnoush
- Shima Salimi
- Pegah Karimi Elizee
- Mehran Ghazimoghaddam
- Seyed Moayed Alavian
2. Impact of New Hepatitis C Treatments in Different Regions of the World
- Lai Wei
- Anna S.F. Lok
3. The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy
- Seyyed Mohammad Miri
- Heidar Sharafi
- Ali Pouryasin
- Bita Behnava
- Maryam Keshvari
- Shima Salimi
- Pegah Karimi Elizee
- Seyed Moayed Alavian
4. Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection
- Farah Bokharaei-Salim
- Mostafa Salehi-Vaziri
- Farzin Sadeghi
- Khadijeh Khanaliha
- Maryam Esghaei
- Seyed Hamidreza Monavari
- Seyed Moayed Alavian
- Shahin Fakhim
- Hossein Keyvani
5. Interleukin 28B Genetic Polymorphism and Spontaneous Recovery from Hepatitis B Virus Infection in an Iranian Azeri Population
- Jafar Mehdizadeh Baghbani
- Sousan Mirnajd Gerami
- Morteza Ghojazadeh
- Morteza Jabbarpour Bonyadi
- Mohammad Hossein Somi
6. The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection
- Fateme Zare
- Hossein Hadinedoushan
- Mohsen Akhondi Meybodi
- Mahdi Dehghanmanshadi
- Seyyed Ali Mirghanizade Bafghi
- Mahmood Vakili
7. Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran
- Mansour Moghimi
- Forough Tavakoli
- Masoud Doosti
- Abbas Ahmadi-Vasmehjani
- Mohsen Akhondi-Meybodi
8. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C
- Mohammad Pouryasin
- Maryam Keshvari
- Heidar Sharafi
- Seyed Moayed Alavian
- Bita Behnava
- Seyed Ehsan Alavian
- Ali Pouryasin
9. Impact of the IL-10 Promoter Gene Polymorphisms in the Severity of Chronic Hepatitis B Infection
- Sahand Ghaleh Baghi
- Seyed Moayed Alavian
- Leila Mehrnoush
- Shiva Salimi
10. Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C
- Maryam Keshvari
- Seyed Moayed Alavian
- Bita Behnava
- Ali Pouryasin
- Johanna C. Craig
- Heidar Sharafi
11. Influence of IL-28B serum level and gene polymorphism in a sample of Iraqi patients with ankylosing spondylitis
- Hadeel Waleed Abdulmalek
- Reema Mohammed Abed
- Laith Ahmad Yaaqoob
- Maha Fakhry Altaee
- Zaid Kadim Kamona
12. Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate
- Javad Moayedi
- Tayebeh Hashempour
- Zahra Musavi
- Ehsan Arefian
- Mahmood Naderi
- Mohamad Reza Heidari
- Behzad Dehghani
- Zahra Hasanshahi
- Shahin Merat
13. The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients
- Farah Bokharaei-Salim
- Mostafa Salehi-Vaziri
- Farzin Sadeghi
- Maryam Esghaei
- Seyed Hamidreza Monavari
- Seyed Moayed Alavian
- Shahin Fakhim
- Hossein Keyvani
14. Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
- Valli De Re
- Laura Gragnani
- Elisa Fognani
- Alessia Piluso
- Francesco Izzo
- Alessandra Mangia
- Marina Crovatto
- Graziella Gava
- Pietro Casarin
- Domenico Sansonno
- Vito Racanelli
- Salvatore De Vita
- Pietro Pioltelli
- Laura Caggiari
- Mariangela De Zorzi
- Massimiliano Berretta
- Andrea Gini
- Antonella Zucchetto
- Franco Maria Buonaguro
- Paolo De Paoli
- Anna Linda Zignego
15. The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C
- Danesh Kadjbaf
- Maryam Keshvari
- Seyed Moayed Alavian
- Ali Pouryasin
- Bita Behnava
- Shima Salimi
- Leila Mehrnoush
- Pegah Karimi Elizee
- Heidar Sharafi
16. Interleukin 18 Gene Promoter Polymorphisms and Susceptibility to Chronic Hepatitis B Infection: A Review Study
- Mahsa Motavaf
- Saeid Safari
- Seyed Moayed Alavian
17. Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network
- Forough Sargolzaee Aval
- Nazanin Behnaz
- Mohamad Reza Raoufy
- Seyed Moayed Alavian
18. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
- Heidar Sharafi
- Seyed Moayed Alavian
- Maryam Keshvari
19. Hepatitis C Virus-Infected Responders and Relapsers to Treatment Show Similar Genetic Profiles ofIL28BandIL10Single Nucleotide Polymorphisms
- Suiane Lima de Souza
- Luãnna Liebscher Vidal
- Juliene Ramos
- Cynthia Chester Cardoso
- Henrique Sérgio Moraes Coelho
- Cristiane Alves Villela-Nogueira
- Renata de Mello Perez
- Marcelo Alves Soares
- André Felipe Santos
20. The Impact of Interleukin-28B rs12979860 Polymorphism on Peginterferon-alpha and Ribavirin Combination Therapy in Iranian Patients with Hepatitis C Virus Genotype 1 Infection
- Mahboubeh Hajiabdolbaghi
- Reza Shahsiah
- Mahsa Motavaf
- Tabasom Zavari
21. The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study
- Heidar Sharafi
- Seyed Moayed Alavian
- Bita Behnava
- Ali Pouryasin
- Maryam Keshvari
22. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
- Arghavan Haj-sheykholeslami
23. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients
- Abdolvahab Alborzi
- Tayebeh Hashempour
- Javad Moayedi
- Zahra Musavi
- Gholamreza Pouladfar
- Shahin Merat
24. Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C
- Ana Ruth Araújo
- Vanessa Peruhype-Magalhães
- Jordana Grazziela Alves Coelho-dos-Reis
- Laura Patrícia Viana Chaves
- Tatiane Amábili de Lima
- João Paulo Diniz Pimentel
- Lúcia de Paula
- Carlos Maurício de Almeida
- Andréa Monteiro Tarragô
- Adriana Tateno
- José Eduardo Levi
- Andrea Teixeira-Carvalho
- Olindo de Assis Martins-Filho
- Edson da Fonseca Lira
- Kátia Luz Torres
- Sinésio Talhari
- Adriana Malheiro
25. Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients
- Farah Bokharaei-Salim
- Hossein Keyvani
- Mostafa Salehi-Vaziri
- Farzin Sadeghi
- Seyed Hamidreza Monavari
- Leila Mehrnoush
- Seyed Moayed Alavian
26. Impact of IL28 Genotypes and Modeling the Interactions of HCV Core Protein on Treatment of Hepatitis C
- Tayebeh Hashempour
- Behzad Dehghani
- Zahra Musavi
- Javad Moayedi
- Zahra Hasanshahi
- Jamal Sarvari
- Seyed Younes Hosseini
- Ebrahim Hosseini
- Maryam Moeini
- Shahin Merat